Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03546387 · ClinicalTrials.gov registry record
Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients
A clinical trial of Retinoblastoma and Pediatric Retinoblastoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT03546387 is a study of Retinoblastoma and Pediatric Retinoblastoma that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 75 participants, below the 588-participant average among 15 other Retinoblastoma trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03546387, a study of Retinoblastoma and Pediatric Retinoblastoma, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if there is a difference between the development of the brain (neurodevelopment) in children who have been treated for retinoblastoma with multiple anesthetic exposures, compared with brain development in children who have never had anesthesia.
Conditions Studied
Interventions
- OTHER Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V)
- OTHER California Verbal Learning Test, Children's Version
- OTHER Beery Developmental Test of Visual Motor Integration, 6th edition
- OTHER Grooved Pegboard Test
- OTHER Behavior Assessment System for Children/Parent Report
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2018-05-07 |
| Est. Completion | 2026-05-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03546387
The ClinicalTrials.gov registry entry for NCT03546387 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 588-participant average among 15 other Retinoblastoma trials with a reported enrollment target (87% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Retinoblastoma appearing as the primary indexed condition, and to 5 interventions - of which Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) is the first listed.
NCT03546387 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03546387 about?
NCT03546387 is a clinical study titled "Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients". The purpose of this study is to see if there is a difference between the development of the brain (neurodevelopment) in children who have been treated for retinoblastoma with multiple anesthetic exposures, compared with brain development in children who have never had anesthesia.
What is the current status of trial NCT03546387?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2018-05-07. Estimated completion is 2026-05-07.
What conditions does trial NCT03546387 study?
This clinical trial studies the following conditions: Retinoblastoma, Pediatric Retinoblastoma.
What interventions are being tested in trial NCT03546387?
The interventions under investigation include: Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) (OTHER), California Verbal Learning Test, Children's Version (OTHER), Beery Developmental Test of Visual Motor Integration, 6th edition (OTHER), Grooved Pegboard Test (OTHER), Behavior Assessment System for Children/Parent Report (OTHER).
Who is sponsoring clinical trial NCT03546387?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03546387 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinoblastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
RB Liquid Biopsy Biorepository
RECRUITING
-
GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
RECRUITING · Phase 1
-
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
RECRUITING
-
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RECRUITING
-
Retinoblastoma Phase II Expanded Access Clinical Trial
RECRUITING · Phase 2
-
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.